KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares RepurchasedShort-Term Debt repayments
Ratios

Labcorp Holdings (LH) Short-Term Debt repayments (2017 - 2025)

Labcorp Holdings' Short-Term Debt repayments history spans 8 years, with the latest figure at $64.8 million for Q1 2025.

  • For Q1 2025, Short-Term Debt repayments fell 69.26% year-over-year to $64.8 million; the TTM value through Dec 2025 reached $64.8 million, down 97.37%, while the annual FY2025 figure was $64.8 million, 97.37% down from the prior year.
  • Short-Term Debt repayments for Q1 2025 was $64.8 million at Labcorp Holdings, down from $1.5 billion in the prior quarter.
  • Across five years, Short-Term Debt repayments topped out at $1.5 billion in Q3 2024 and bottomed at $64.8 million in Q1 2025.
  • The 4-year median for Short-Term Debt repayments is $609.3 million (2023), against an average of $644.9 million.
  • The largest YoY upside for Short-Term Debt repayments was 234.41% in 2024 against a maximum downside of 74.54% in 2024.
  • A 4-year view of Short-Term Debt repayments shows it stood at $787.4 million in 2022, then fell by 22.62% to $609.3 million in 2023, then soared by 151.37% to $1.5 billion in 2024, then crashed by 95.77% to $64.8 million in 2025.
  • Per Business Quant, the three most recent readings for LH's Short-Term Debt repayments are $64.8 million (Q1 2025), $1.5 billion (Q3 2024), and $721.3 million (Q2 2024).